Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Becherer

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Liver|February 13, 2001
18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liverA Kurtaran, A Becherer, F Pfeffel, et al.
Radiology|February 1, 1997
Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammographyT H Helbich, A Becherer, S Trattnig, et al.
Nuklearmedizin. Nuclear Medicine|November 26, 2014
[Treatment of patients with radioiodine refractory, differentiated thyroid carcinoma. A Consensus Statement]Christina Lindner, J Dierneder, G Pall, et al.
International Journal of Cancer|July 15, 1998
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristicsT M Wagner, R A Möslinger, D Muhr, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Liver|February 13, 2001
18F-fluorodeoxyglucose (FDG)-PET features of focal nodular hyperplasia (FNH) of the liverA Kurtaran, A Becherer, F Pfeffel, et al.
Radiology|February 1, 1997
Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammographyT H Helbich, A Becherer, S Trattnig, et al.
Nuklearmedizin. Nuclear Medicine|November 26, 2014
[Treatment of patients with radioiodine refractory, differentiated thyroid carcinoma. A Consensus Statement]Christina Lindner, J Dierneder, G Pall, et al.
International Journal of Cancer|July 15, 1998
BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristicsT M Wagner, R A Möslinger, D Muhr, et al.
Pageof 4